Trial Profile
Coagaulation in patients with atrial fibrillation: The effect of dabigatran
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 07 Jul 2016
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Thrombosis
- Focus Therapeutic Use
- 02 Jul 2016 Status changed from recruiting to discontinued.
- 01 Apr 2015 New trial record